Minnesotans with autism and obstructive sleep apnea will be able to use medical marijuana as of next July to manage their medical conditions.
Tag Archives: Health Commissioner
Today, the New Jersey Medicinal Marijuana Program Review Panel made initial recommendations to the Health Commissioner to approve chronic pain, migraine, anxiety and Tourette’s Syndrome as qualifying conditions for the medical marijuana program.
On May 16, 2017, the Minnesota Department of Health announced that a recent study shows a majority of patients enrolled in the Minnesota Medical Cannabis Program have reported medical cannabis benefitting their conditions.
ST. PAUL, Minn., May 16, 2017 /Weed Wire/ — A majority of Minnesota patients using medical cannabis reported benefits during the first year of the program, according to early data from a first-of-its-kind study by the Minnesota Department of Health (MDH).
New Jersey might get an influx of new medical marijuana patients. On May 11, 2017, the New Jersey Medicinal Marijuana Program Review Panel suggested that the state health commissioner add chronic pain as a qualifying condition.
TRENTON, N.J., May 11, 2017 /Weed Wire/ — Today, the New Jersey Medicinal Marijuana Program Review Panel made initial recommendations to the Health Commissioner to approve chronic pain related to musculoskeletal disorders, migraines, anxiety, chronic fatigue related to ailments such as irritable bowel syndrome, Tourrette syndrome as qualifying conditions for the medical marijuana program.
On Dec. 8, 2016, the New York State Department of Health announced several updates to its medical marijuana program, most notably the approval of medical marijuana wholesaling and lifting the cap on the number of available products for patients.
The change comes as the number of patients using medical marijuana and doctors prescribing it continues to grow.